| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/31/2001 | EP1071771A2 Gene encoding syntaxin interacting protein |
| 01/31/2001 | EP1071770A2 Glaucoma therapeutics and diagnostics based on a novel human transcription factor |
| 01/31/2001 | EP1071769A1 Secretion of glycosylated proteins using a tissue plasminogen activator pro-sequence |
| 01/31/2001 | EP1071767A1 Gene coding for heliomicine and use thereof |
| 01/31/2001 | EP1071766A1 HUMAN G-PROTEIN COUPLED RECEPTOR GPR6sb |
| 01/31/2001 | EP1071765A1 Alk-1 responds to tgf-beta and signals through smad-1 and smad-5 |
| 01/31/2001 | EP1071764A1 ANTISENSE OLIGONUCLEOTIDES FOR THE INHIBITION OF INTEGRIN $g(a) v?-SUBUNIT EXPRESSION |
| 01/31/2001 | EP1071763A1 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates |
| 01/31/2001 | EP1071758A1 Porcine adenovirus type 3 genome |
| 01/31/2001 | EP1071757A2 Combination of genes for regulating flowering induction in useful and ornamental plants |
| 01/31/2001 | EP1071751A1 TRANSGENIC MAMMALS EXPRESSING MUTANT GP IIIa |
| 01/31/2001 | EP1071750A1 Pns cell lines and methods of use therefor |
| 01/31/2001 | EP1071749A1 Novel lrsg protein and nucleic acid molecules and uses therefor |
| 01/31/2001 | EP1071748A1 EXPRESSION OF $i(ALFIN1) AND METHODS FOR PRODUCING TRANSGENIC PLANTS HAVING INCREASED ROOT GROWTH AND ROOT SPECIFIC GENE ACTIVATION |
| 01/31/2001 | EP1071718A1 Matrix binding factor |
| 01/31/2001 | EP1071717A1 Mutagenized il13-based chimeric molecules |
| 01/31/2001 | EP1071716A1 Process for concentrating protein with disease-related conformation |
| 01/31/2001 | EP1071715A2 TRANSFERRIN RECEPTOR GENES OF $i(MORAXELLA) |
| 01/31/2001 | EP1071714A1 A novel g-protein coupled receptor |
| 01/31/2001 | EP1071713A2 Srebp-1 and srebp-2 in a phosphorylated form |
| 01/31/2001 | EP1071712A1 Sp22, a fertility-associated protein from sperm and a method for evaluating and affecting male fertility using it |
| 01/31/2001 | EP1071711A1 Process for the recovery and purification of a recombinant protein from a cell |
| 01/31/2001 | EP1071710A2 Genomic sequence of the 5-lipoxygenase-activating protein (flap), polymorphic markers thereof and methods for detection of asthma |
| 01/31/2001 | EP1071709A2 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 01/31/2001 | EP1071708A1 Edg family gene, human h218 |
| 01/31/2001 | EP1071707A1 Novel omega conotoxin peptides |
| 01/31/2001 | EP1071706A1 Rapidly degrading gfp-fusion proteins and methods of use |
| 01/31/2001 | EP1071705A2 Peptides causing formation of compact structures |
| 01/31/2001 | EP1071704A1 Novel matrix metalloproteinase inhibitors and down-regulators |
| 01/31/2001 | EP1071701A1 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof |
| 01/31/2001 | EP1071698A1 Nucleic acid sequences and proteins associated with aging |
| 01/31/2001 | EP1071697A1 Regulated target expression for screening |
| 01/31/2001 | EP1071694A1 Staphylococcus aureus spo0j2: polynucleotide and protein |
| 01/31/2001 | EP1071475A2 Cd4 radio-immunological pharmaceuticals for the treatment of hiv infections |
| 01/31/2001 | EP1071472A1 Peptides for efficient gene transfer |
| 01/31/2001 | EP1071460A1 INTERNALIZING ErbB2 ANTIBODIES |
| 01/31/2001 | EP1071456A1 Vaccines with an ltb adjuvant |
| 01/31/2001 | EP1071451A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 01/31/2001 | EP1071449A2 Antagonists of the inflammatory mediator oncostatin m (osm) |
| 01/31/2001 | EP1071447A1 Treatment for diabetes |
| 01/31/2001 | EP1071443A1 Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein bind to mhc class i and mhc class ii molecules, and uses thereof |
| 01/31/2001 | EP1071442A1 Methods and compositions for peptide synthesis |
| 01/31/2001 | EP1071434A1 Cnre binding factors and uses thereof |
| 01/31/2001 | EP1071334A1 A method for efficient and highly selective control of microorganisms |
| 01/31/2001 | EP0920528A4 Synthetic protein folding catalysis |
| 01/31/2001 | EP0724639B1 Methods for selection of recombinant host cells expressing high levels of a desired protein |
| 01/31/2001 | EP0619732B1 Biodegradable polymers for cell transplantation |
| 01/31/2001 | EP0610356B1 Treatment of bacterial dysentery |
| 01/31/2001 | CN1282374A Bacterial resistance in grapevine |
| 01/31/2001 | CN1282372A Mammalian sytokine-like polypeptide-10 |
| 01/31/2001 | CN1282371A Ac (DNA encoding C6 beta-chemokine leukotactin-1 (Lkn-1) isolated from human |
| 01/31/2001 | CN1282338A A DNA molecule encoding mutant prepro-neuropeptide Y, a mutant signal peptide, and uses thereof |
| 01/31/2001 | CN1282255A IFNAR2/I FN complex |
| 01/31/2001 | CN1282251A Method and material for treating and preventing mucosal tissue inflammation |
| 01/31/2001 | CN1281898A Human zinc finger protein isomer and its code sequence |
| 01/31/2001 | CN1281897A Human thioredoxin related protein and its code sequence |
| 01/31/2001 | CN1281896A Human nuclear receptor factor protein an its code sequence |
| 01/31/2001 | CN1281895A Human mitochondrial solute carrier protein isomer and its code sequence |
| 01/31/2001 | CN1061373C Method for preparing monomer insulin |
| 01/30/2001 | US6180850 Ku70 is the noncatalytic subunit of dna-protein kinase, encoded by specified polynucleotides; transgenic plants; modulating the level of ku70 in a plant; modulating nucleic acid expression in plants |
| 01/30/2001 | US6180849 Trangenic mice with a disruption in the tiar gene |
| 01/30/2001 | US6180776 MTS2 gene |
| 01/30/2001 | US6180775 Bacillus thuringiensis isolates active against weevils |
| 01/30/2001 | US6180773 The cc type chemokines belong to a family of polypeptides which have proven to be mediators of immune reactions, and which have antiviral activity with respect to hiv |
| 01/30/2001 | US6180772 Nucleic acids encoding dominant negative I-κ-B -α polypeptides |
| 01/30/2001 | US6180771 Given nucleotide sequence; useful for pharmaceutical administration or methods of diagnosing sensitivity to house dust mites |
| 01/30/2001 | US6180767 Peptide nucleic acid conjugates |
| 01/30/2001 | US6180763 Cyclin D binding factor, and uses thereof |
| 01/30/2001 | US6180761 Casein from Korean cattle |
| 01/30/2001 | US6180760 Of given amino acid sequence, a cdna sequence, and antibody specifically recognizing 1-afadin; 1-afadin contributes to the cell-to-cell adherens junction (aj) having a role in individual formation of animals and pathigenesis |
| 01/30/2001 | US6180758 Synthetic peptides for rubella vaccine |
| 01/30/2001 | US6180752 Polyasparaginic acid homopolymers an copolymers, biotechnical production and use thereof |
| 01/30/2001 | US6180646 Retroviral protease inhibitors |
| 01/30/2001 | US6180614 Methods of immunization of aquaculture species by introducing dna expression systems into the aquaculture species |
| 01/30/2001 | US6180613 AAV-mediated delivery of DNA to cells of the nervous system |
| 01/30/2001 | US6180610 Tetrapeptide |
| 01/30/2001 | US6180607 Employed as therapeutics in diseases such as emphysema, idiopathic pulmonary fibrosis, adult respiratory distress syndrome, cystic fibrosis, rheumatoid arthritis, organ failure, and glomerulonephritis |
| 01/30/2001 | US6180604 Compositions and methods for treating infections using analogues of indolicidin |
| 01/30/2001 | US6180602 Derived from mrnas expressed in human cells |
| 01/30/2001 | US6180600 CD8 antagonists |
| 01/30/2001 | US6180598 Covalently modified hemoglobin having low temperature-dependent oxygen-binding function |
| 01/30/2001 | US6180406 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 01/30/2001 | US6180391 Vector for cloning preferential heterologous nucleotide sequences |
| 01/30/2001 | US6180389 Virion-constrained nanoparticles comprising a plant virion coat protein shell and encapsulated guest molecules |
| 01/30/2001 | US6180385 Nucleotide sequences coding a viral enzymatic polypeptide; for the detection of modulators of proteolytic activity |
| 01/30/2001 | US6180384 Compounds |
| 01/30/2001 | US6180383 Insect proteolytic enzyme; for the prevention of insect infestation |
| 01/30/2001 | US6180380 Cloning of a new member of the serine threonine kinase family |
| 01/30/2001 | US6180379 Eukaryotic transport protein; for utilization in the ubiquination and degradation of cell cycle polypeptides |
| 01/30/2001 | US6180371 Modified factor VIII |
| 01/30/2001 | US6180370 Preparing preferential antibodies; generating nucleotide sequences coding preferential antibodies, expressing nucleotide sequences in transformed cell and recovering preferential antibodies |
| 01/30/2001 | US6180369 Varicella-zoster virus antigen |
| 01/30/2001 | US6180368 Ryegrass pollen allergen |
| 01/30/2001 | US6180367 Recovering heterologous proteins from microorganisms; culture transformed microorganismal cells with expression vector, incubate with inducer, propagate, lyse cells and recover accumulated heterologous protein |
| 01/30/2001 | US6180365 Expression vector coding membrane binding polypeptide; for use in diagnosis and treatment of bacterial, fungal or viral infection |
| 01/30/2001 | US6180364 Protein called epil/placentin, process for the preparation of this protein and pharmaceutical composition containing such, DNA coding for said protein |
| 01/30/2001 | US6180362 Peptides which inhibit ras protein activity, their preparation and use |
| 01/30/2001 | US6180355 Method for diagnosing and treating chronic pelvic pain syndrome |
| 01/30/2001 | US6180345 Process for simultaneous preparation of sex specific and gender-neutral semisynthetic amplicons useful for sex determination |
| 01/30/2001 | US6180344 5′ Upstream region sequences of the MyoD1 gene and uses thereof |